Atlas Trials

Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody)

Clinical trial NCT05453435 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05453435
Sponsor
Sun Yat-sen University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Resolved Hepatitis BCD20 Positive B-cell Lymphoma
Start date
2022-07-15
Primary completion
2026-12-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.